Major pharma firms deploy Perceptive DataLabs EDC Solution
The DataLabs EDC solution is believed to simplify workflows and streamline the process from study design to data collection, management, and reporting. The solution is offered as a
China-based Biocytogen Pharmaceuticals has entered a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule.
Sygnature and Cyprotex will extend their collaborative sales and marketing initiative to provide discovery chemistry/ADME-Tox/DMPK service to accelerate their clients’ drug discovery projects into development. Cyprotex CEO Anthony